Sulfated colominic acid: an antiviral agent that inhibits the human immunodeficiency virus type 1 in vitro
- 1 June 1996
- journal article
- Published by Elsevier BV in Antiviral Research
- Vol. 31 (1-2), 95-104
- https://doi.org/10.1016/0166-3542(96)00957-6
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Inhibition of infection with human immunodeficiency virus type 1 by sulfated gangliosidesBiochemical and Biophysical Research Communications, 1991
- Pharmacokinetic Analysis of Dextran Sulfate in Rats as Pertains to Its Clinical Usefulness for Therapy of HIV InfectionAIDS Research and Human Retroviruses, 1990
- Characteristic mode of action of gangliosides in selective modulation of CD4 on human T lymphocytesBiochemical and Biophysical Research Communications, 1989
- Activity of Dextran Sulfate and Other Polyanionic Polysaccharides Against Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1988
- PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)The Lancet, 1988
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAVNature, 1984
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983